We also showed that NOX4 inhibition could reverse TGF-β1 mediated CAF activation, leading to reduced extra-cellular matrix (ECM) deposition, increased CD8+ T-cell infiltration into tumours and improved immunotherapy efficacy. Here, CD8A is linked to neoplasm.